- Frontline Strategy’s IIG Fund takes 26% stake in Shriram SEPL Composites
- Frontline Strategy's IIG Fund invests USD 7 mn in Krishna Saa Fabs
- Frontline Strategy’s IIGF buys stake in Tejas Networks, in a secondary transaction
- Frontline Strategy’s SVF fully exits another investment in India
- Frontline Strategy’s SVF fully exits Titagarh Wagons in India
- Frontline Ventures (Entrepreneur Magazine)
- Frontline Strategy launches Fund III – USD150m fund shall invest in mid-market Indian companies
- Frontline Strategy’s IIGF increases its stake in Tejas Networks, through a secondary transaction
Frontline Strategy launches Fund III – USD150m fund shall invest in mid-market Indian companies
- Frontline Strategy has a decade-long, top-decile investing track record in Indian private equity
- Fund III – the Clove Route Fund – will invest in medium-sized Indian companies for growth capital and special situations
- Each investment is likely to be in the USD10-15m range
Mauritius, August 25, 2010:Frontline Strategy Limited today announced the launch of its third fund – the USD 150 million Clove Route Fund. The fund will make private equity investments in India's medium sized companies for growth capital and special situations.
Frontline seeks to build upon its decade-long, top-decile performance, compared with other Indian/Asian private equity funds of similar vintage. Frontline will leverage its past experience from Fund I and Fund II, while adding further capability for value creation through connectivity to Indonesia.
Frontline’s investment strategy and focus is to identify investments in growth capital, consolidation and special situations in sectors such as industrials, resources, healthcare, consumer, agricultural derivatives and technology. Each investment is likely to be in the USD 10-15 million range over the lifecycle of the investment.
The Clove Route Fund is Frontline’s third private equity fund. Fund I, Strategic Ventures Fund, has nearly completed its entire lifecycle of investments and exits. Fund II, India Industrial Growth Fund, is the process of completing its investment cycle.
About Frontline Strategy: Founded in 2000, Frontline Strategy Limited (www.frontlinestrategy.com) is a private equity advisory company. The firm has established a very strong track record in private equity investing over the past decade in India, with a total of 18 investments, 10 exits and 2 partial exits. Frontline’s Fund-I has a top-decile performance compared with similar vintage Indian and Asian private equity funds. Fund-I’s net IRR of 23%+ over 9 nine has been generated through multiple investments and exits, and not through just 1-3 investments.
The Investment Management team has a cumulative and diverse experience of over 120 years across investment management, equity research and investment banking, commercial banking and company operations. The team also includes members who have been angel investors and have co-founded companies. Key members of the team include: Atim Kabra, Founding and General Partner; Supratim Basu, General Partner; J Venkatadas, Principal and Vipin Aggarwal, Principal. The first two funds have been anchored by the Fabiani Family Office, represented by Harish and Kamal Fabiani who will be a Venture Partner in Fund III along with Raman Kumar, CEO of Cbay Systems Limited. Frontline plans to add two more senior investment professionals to the team on the closure of Fund III.
Prominent investments of Frontline’s first fund, Strategic Venture Fund (Mauritius) Limited, include: CBay Systems & Services, Inc, the largest provider of outsourced knowledge processing services for the global healthcare industry (http://www.cbaysystems.com/); Astra Microwave Products, a manufacturer of high-end microwave and RF-based components for defence, space and civil telecom applications (http://www.astramwp.com/); Titagarh Wagons, India's leading private manufacturer of railway wagons (http://www.titagarh.biz/); Alfa Transformers, a manufacturer of power, distribution and furnace (specialty) transformers (http://www.alfatransformerlimited.com/); Shilpa Medicare, among India's leading specialty pharmaceutical manufacturers, primarily focusing on custom synthesis and oncology APIs (http://www.vbshilpa.com/).
Prominent investments of Frontline’s second fund, India Industrial Growth Fund Limited, include: Tejas Networks, a global top-10 OEM in the space of optical networking products (http://www.tejasnetworks.com/); Shriam SEPL Composites, India’s leading manufacturer of composite material pipes, used in water, sewage and oil and gas sectors.
CONTACTS
- Atim Kabra
- Singapore
- atim@frontlinestrategy.com
- Supratim Basu
- India
- supratim@frontlinestrategy.com